Now there is a treatment for your double chin! The FDA has approved KYBELLA™ (deoxycholic acid) injection, which contours and improves the appearance of moderate to severe submental fullness due to submental fat. Submental fullness, also known as "double chin" can affect adult women and men of all ages and weights, and is influenced by multiple factors, including aging and genetics. Submental fullness is often resistant to diet and exercise, and according to a 2014 survey conducted by the American Society for Dermatologic Surgery, 68 percent of people said they are bothered by their double chin.
KYBELLA™ is a formulation of a naturally occurring substance (deoxycholic acid) that targets and destroys fat cells in the area where it's injected. Once those cells are destroyed, they can no longer store or accumulate fat. Once the aesthetic response is achieved with KYBELLA™, re-treatment is not expected to be required.
The treatment process involves injecting KYBELLA™ into the chin area. Most patients will require a minimum of two treatments, with a four to six week period between the first and second treatment. There are no surgical incisions, and individuals should be able to quickly return to their normal activities. The most common side effects are typically local to the treatment area and most commonly include swelling, bruising, pain, numbness, tingling, hardness and redness. KYBELLA™ can cause serious side effects, including trouble swallowing and nerve injury in the jaw that can cause an uneven smile or facial muscle weakness.
Dr. Goh cautions that KYBELLA™ may not be the right choice for everyone. Patients must be 18 years or older to receive this treatment. Also, if an individual has significant skin laxity in addition to fatty tissue under the chin, a different approach may be recommended since KYBELLA™ is not designed to tighten the skin. Those individuals with a history of a previous cosmetic procedure in the facial/neck area such as a face lift, neck lift, liposuction, Smartlipo, and certain other surgical procedures in the area are not candidates for KYBELLA™. Individuals with an auto immune deficiency, or anyone with an active infection in the face/chin area are not candidates for the product. Those women who are pregnant or breastfeeding, or plan to be are also not candidates for KYBELLA™
Individuals on anti-coagulant drugs (blood thinners) may be candidates for KYBELLA if they receive written approval from the physician who initiated the drug therapy. The approval must contain the maximum number of days the patient is approved to be off of the drug therapy, this written approval must be secured before scheduling your consultation for KYBELLA evaluation.
Before and After KYBELLA™ photo gallery
Call today and schedule your KYBELLA™ evaluation (843) 497-2227